Login / Signup

Direct factor Xa inhibitors and the risk of cancer and cancer mortality: A Danish population-based cohort study.

Floris T M BoschErzsébet Horváth-PuhóSuzanne C CannegieterNick Van EsHenrik Toft Sorensen
Published in: PLoS medicine (2024)
In this population based cohort study, factor Xa inhibitor use was not associated with an overall lower incidence of cancer or cancer-related mortality when compared to dabigatran. We did observe an increase in all-cause mortality in the factor Xa inhibitor cohort.
Keyphrases
  • papillary thyroid
  • squamous cell
  • risk factors
  • cardiovascular events
  • squamous cell carcinoma
  • cardiovascular disease
  • coronary artery disease
  • young adults